Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert A. Mello currently holds 28,178 shares of ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert A. Mello has been a net seller of HRT stock. They have purchased $28.3K and sold $2.1M worth of shares.
Robert A. Mello's most recent insider trade was on Nov 18, 2019, when they sold 1,589 shares at $2.36 per share.
Robert A. Mello serves as Executive at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT). They have executed 82 insider transactions totaling $2.1M over their tenure at the company.
Robert A. Mello holds the position of Executive at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Robert A. Mello has shown a selling trading pattern, with $28.3K in total purchases and $2.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert A. Mello was on Oct 31, 2012, when they sold $1.3M worth of IRIS shares. This transaction involved 68,809 shares at $19.50 per share.
Robert A. Mello currently owns 28,178 shares of ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert A. Mello's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert A. Mello has 82 Form 4 filings on record as an insider at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/.
Set alerts for Robert A. Mello and 40,000+ other insiders.